Tags
- A
- Accelerated
- Accessibility
- Accumulation
- Activation
- Acute
- Administration
- Adult
- Alternative
- American Heart
- American Heart Association
- An
- Anakinra
- Andrew Hamer
- Anthony Moore
- Anticipation
- Anti-inflammatory
- Application
- Approval
- Approximately
- Archer Trial
- Archery
- Asse
- Assembly
- Assessment
- Assist
- Association
- Augment
- Authorization
- Baseline
- Basis
- Biopharmaceutical
- Blinded experiment
- Blocker
- Body
- Body of Evidence
- Breath
- Candidate
- Cannabidiol
- Cardiac
- Cardiac Arrest
- Cardiovascular disease
- Cause
- Cause of death
- Cautionary
- Centre
- CEO
- Cessation
- Characteristic
- Chest
- Chest pain
- Chief
- Chief Medical Officer
- Chronic
- Clinical
- Clinical data
- Clinical endpoint
- Clinical endpoints
- Clinical trial
- Collaboration
- Combination therapy
- Comprise
- Comprised of
- Conduct
- Constriction
- Containment
- Cost-effectiveness analysis
- Costly
- C-reactive protein
- CRP
- Cytokine
- Data
- David Elsley
- Death
- Defined
- Dependant
- Dependency
- Designation
- Developed country
- Development
- Discontinuation
- Disease
- Downstream
- DR
- Drug
- Drug development
- Drug discovery
- Efficacy
- Efficacy endpoint
- Elevated
- Emergency
- Emergency department
- End
- Endpoint
- Endpoints
- Episode
- Estimation
- Europe
- Evaluation
- Evidence
- Execution
- Expectation
- Expense
- Experienced
- Experiment
- Exploring
- Fact
- Failure
- Fatigue
- FDA
- Fda-approved
- Fibrosis
- Financial regulation
- Five
- Fluid
- Focus
- Following
- Follow-on
- Food
- Food and Drug Administration
- Formulation
- Forward-looking
- Fourth
- Fourth quarter
- Freedom
- Freedom From
- Frequently
- Fulminant
- Generation
- Goal
- Hamer
- Having
- Health care
- Healthcare cost
- Health care prices in the United States
- Heart
- Heart failure
- Historical fact
- Hospital
- IL-1
- Immunosuppressive drug
- Impact
- Impaction
- Include
- Includes
- Inequality
- Infection
- Inflammasome
- Inflammation
- Inflammatory
- Inform
- Inhibitor
- Initial
- Initiate
- Initiation
- Intention
- Interleukin-1 family
- International
- Interval
- Intervention
- Intolerance
- Into the Now
- Intracellular
- Investigation
- Investigational New Drug
- Known
- Length
- Length of stay
- Less
- Lethality
- Levels
- Life science
- Life Sciences
- Limitations
- Long term
- Manufacturing
- Marked
- Marker
- Market
- Market potential
- Measurement
- Medical
- Medical Officer
- Membrane
- Molecule
- Myocarditis
- NALP3
- NASDAQ
- Need
- Negation
- New
- New drug application
- Normalization
- Novel
- Number
- Offering
- Officer
- Only
- Onset
- Option
- Options
- Oral administration
- Oral solution
- Orphan
- Orphan drug
- Pain
- Panel
- Path
- Pathophysiology
- Pathway
- Patient
- Pericardial
- Pericardial disease
- Pericardial fluid
- Pericarditis
- Pericardium
- Periodic fever syndrome
- Pharmaceutical drug
- Pharmaceutical formulation
- Phase
- Phase II
- Phase III
- Physical
- Pivotal
- Pivotal trial
- Placebo
- Placebo-controlled study
- Planning
- Population
- Positive
- Presentation
- Presenting
- Press release
- Prevention
- Primary
- Programmer
- Progressed
- Progression
- Proinflammatory cytokine
- Protein
- Public speaking
- Q4
- Quality
- Quality of life
- Quarter
- Randomness
- Range
- Rapid
- Recognized
- Recurrence
- Recurrence relation
- Recurrent pericarditis
- Reduction
- Reductions
- Refer
- Regulation
- Require
- Rescue
- Research
- Research and development
- Result
- Rilonacept
- Risk
- Route of administration
- Safety
- Science
- Scientific
- Score
- Second
- Security
- Seek
- Session
- Sessions
- Shortness
- Shortness of breath
- Shown
- Small molecule
- Small molecule drug
- Solution
- Stable
- Statements
- Stay
- Still
- Studie
- Subcutaneous tissue
- Subsequent
- Subset
- Substantial
- Sudden
- Suffer
- Suffering
- Surround
- Symptom
- Symptoms
- Target
- The american
- The end
- The heart
- The Meaning
- Therapeutic potential
- Therapy
- The trial
- Third
- Thousand
- Timeline
- Today
- Tolerability
- Totality
- Trial
- TSX
- United State
- Versus
- Viral
- Viral disease
- Visit
- Weaning
- Who
- Young adult